Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21273939 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age
Condition: HPV-16/18 Infections and Cervical Neoplasia
Intervention: Biological: Cervarix TM

Indicates status has not been verified in more than two years